Ripol

Ripol may be available in the countries listed below.

Ingredient matches for Ripol

Sildenafil

Sildenafil is reported as an ingredient of Ripol in the following countries:

• Chile

International Drug Name Search

dextroamphetamine

dex-troe-am-FET-a-meen

Oral route(Tablet;Capsule, Extended Release)

Amphetamines have a high potential for abuse, and administration for prolonged periods of time may lead to drug dependence and must be avoided. Misuse of amphetamines may cause sudden death and serious cardiovascular adverse events .

Commonly used brand name(s)

In the U.S.

• Dexedrine


• Dexedrine Spansules


• Dextrostat


• Liquadd


• ProCentra

Available Dosage Forms:

• Capsule, Extended Release


• Solution


• Tablet

Therapeutic Class: CNS Stimulant

Chemical Class: Amphetamine (class)

Uses For dextroamphetamine

Dextroamphetamine belongs to the group of medicines called central nervous system (CNS) stimulants. It is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy (uncontrollable desire for sleep or sudden attacks of deep sleep) .

Dextroamphetamine increases attention and decreases restlessness in patients who are overactive, cannot concentrate for very long or are easily distracted, and have unstable emotions. It is also used as part of a total treatment program that also includes social, educational, and psychological treatment .

dextroamphetamine is available only with a doctor's prescription. Prescriptions cannot be refilled. A new prescription must be obtained from your doctor each time you or your child needs dextroamphetamine .

Before Using dextroamphetamine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dextroamphetamine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to dextroamphetamine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of dextroamphetamine in children with attention-deficit hyperactivity disorder below 3 years of age. Safety and efficacy have not been established .

Dextroamphetamine sustained-release capsule is not recommended in children below 6 years of age .

Geriatric

No information is available on the relationship of age to the effects of dextroamphetamine in geriatric patients .

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using dextroamphetamine.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dextroamphetamine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using dextroamphetamine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Clorgyline


• Furazolidone


• Iproniazid


• Isocarboxazid


• Moclobemide


• Nialamide


• Pargyline


• Phenelzine


• Procarbazine


• Selegiline


• Sibutramine


• Toloxatone


• Tranylcypromine

Using dextroamphetamine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Citalopram


• Venlafaxine

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Other Medical Problems

The presence of other medical problems may affect the use of dextroamphetamine. Make sure you tell your doctor if you have any other medical problems, especially:

• Agitation, anxiety, or tension or


• Arteriosclerosis (hardening of the arteries), severe or


• Drug abuse or dependence, history of or


• Glaucoma or


• Heart disease or


• High blood pressure, moderate to severe or


• Overactive thyroid—dextroamphetamine should not be used in patients with these conditions .

• Heart problems or defects or


• High blood pressure, mild or


• Mental illness (e.g., aggressive behavior, hostility, psychosis, mania, family history of suicide, bipolar illness, depression) or


• Seizures, history of or


• Thyroid problems—Use with caution. Serious side effects may occur .

• Tourette's syndrome, history of or other tics—Children and their families should be checked by their doctor for this condition before taking dextroamphetamine .

Proper Use of dextroamphetamine

Take dextroamphetamine only as directed by your doctor. Do not take more or less of it, do not take it more often, and do not take it for a longer time than your doctor ordered. If too much is taken, it may become habit-forming (causing mental or physical dependence) .

If you or your child think dextroamphetamine is not working properly after you have taken it for several weeks, do not increase the dose. Instead, check with your doctor .

dextroamphetamine should come with a Medication Guide. Read and follow these instructions carefully. Ask your doctor if you have any questions .

If you or your child use the tablet form of dextroamphetamine, and you take it two or three times a day. Take the first dose in the morning. The other doses may be taken during the day with 4 to 6 hours between doses .

It is best to take the sustained-release capsule in the morning. Taking dextroamphetamine in the afternoon or evening could make it harder for you to fall asleep .

Swallow the sustained-release capsule whole. Do not crush, break, or chew it .

Dosing

The dose of dextroamphetamine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dextroamphetamine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For attention-deficit hyperactivity disorder (ADHD):):
  
  • For oral dosage form (tablets):
    
    • Adults and children 6 years of age and older—At first, 5 milligrams (mg) one or two times a day. Your doctor may adjust your dose if needed.
    
    
    • Children 3 to 5 years of age—At first, 2.5 mg once a day. Your doctor may adjust your dose if needed.
    
    
    • Children younger than 3 years of age—Use and dose must be determined by your doctor .
    
    
  
  
  • For oral dosage form (sustained-release capsules):
    
    • Adults and children 6 years of age and older—At first, 5 milligrams (mg) one or two times a day. Your doctor may adjust your dose if needed.
    
    
    • Children younger than 6 years of age—Use and dose must be determined by your doctor .
    
    
  
  

• For narcolepsy:
  
  • For oral dosage form (tablets or sustained-release capsules):
    
    • Adults and children 12 years of age and older—At first, 10 milligrams (mg) once a day. Your doctor may adjust your dose if needed.
    
    
    • Children 6 to 12 years of age—At first, 5 milligrams (mg) once a day. Your doctor may adjust your dose if needed.
    
    
    • Children younger than 6 years of age—Use and dose must be determined by your doctor .
    
    
  
  

Missed Dose

If you miss a dose of dextroamphetamine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using dextroamphetamine

It is very important that your doctor check your progress at regular visits to make sure dextroamphetamine is working properly and to check for unwanted effects .

If you or your child will be taking dextroamphetamine in large doses for a long time, do not stop taking it without first checking with your doctor. Your doctor may want you or your child to gradually reduce the amount you are taking before stopping it completely .

Do not take dextroamphetamine within 14 days of taking an MAO inhibitor such as Eldepryl®, Marplan®, Nardil®, or Parnate®.

dextroamphetamine may cause some people to feel a false sense of well-being or to become dizzy, lightheaded, or less alert than they are normally. Make sure you know how you react to dextroamphetamine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.

Check with your doctor immediately if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you or your child to have your eyes checked by an ophthalmologist (eye doctor) .

If you or your child have been using dextroamphetamine for a long time and you think you may have become mentally or physically dependent on it, check with your doctor. Some signs that you may be dependent on dextroamphetamine are:

• A strong desire or need to continue taking the medicine.


• A need to increase the dose to receive the effects of the medicine.


• Withdrawal effects (for example, mental depression, nausea or vomiting, stomach cramps or pain, trembling, unusual tiredness or weakness) that occur after the medicine is stopped .

dextroamphetamine may cause slow growth in children. If your child is using dextroamphetamine, the doctor will need to keep track of your child's height and weight to make sure that your child is growing properly .

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements .

dextroamphetamine Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Rare

• Agitation


• delusions


• hallucinations

Incidence not known

• Blurred vision


• chest discomfort or pain


• difficulty breathing


• dizziness


• faintness


• false or unusual sense of well-being


• fast, pounding, or irregular heartbeat or pulse


• headache


• nervousness


• pounding in the ears


• restlessness


• shakiness in legs, arms, hands, or feet


• shortness of breath


• sleeplessness


• swelling of feet or lower legs


• trembling or shaking of hands or feet


• trouble sleeping


• troubled breathing


• twitching, twisting, or uncontrolled repetitive movements of tongue, lips, face, arms, or legs


• unable to sleep


• uncontrolled vocal outbursts and/or tics (uncontrolled repeated body movements)


• unusual tiredness or weakness

Get emergency help immediately if any of the following symptoms of overdose occur:

Symptoms of overdose

• Change in consciousness


• dark-colored urine


• diarrhea


• discouragement


• feeling sad or empty


• fever


• irritability


• lack of appetite


• loss of consciousness


• loss of interest or pleasure


• mood or mental changes


• muscle cramps or spasms


• muscle pain or stiffness


• nausea


• panic state


• physical attempt to injure


• rapid breathing


• seizures


• stomach cramps


• sweating


• trouble concentrating


• trouble sleeping


• violent actions


• vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

• Bad, unusual, or unpleasant (after)taste


• change in taste


• constipation


• decreased interest in sexual intercourse


• dry mouth


• hives or welts


• inability to have or keep an erection


• indigestion


• itching


• loss in sexual ability, desire, drive, or performance


• passing of gas


• redness of skin


• skin rash


• weight loss

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: dextroamphetamine side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More dextroamphetamine resources

• Dextroamphetamine Side Effects (in more detail)
• Dextroamphetamine Use in Pregnancy & Breastfeeding
• Drug Images
• Dextroamphetamine Drug Interactions
• Dextroamphetamine Support Group
• 30 Reviews for Dextroamphetamine - Add your own review/rating

• dextroamphetamine Concise Consumer Information (Cerner Multum)


• Dextroamphetamine MedFacts Consumer Leaflet (Wolters Kluwer)


• Dextroamphetamine Monograph (AHFS DI)


• Dextroamphetamine Prescribing Information (FDA)


• Dexedrine Prescribing Information (FDA)


• Dexedrine Spansule Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)


• Dextrostat Prescribing Information (FDA)


• Liquadd Solution MedFacts Consumer Leaflet (Wolters Kluwer)


• ProCentra Prescribing Information (FDA)

Compare dextroamphetamine with other medications

• ADHD
• Fatigue
• Hypersomnia
• Narcolepsy
• Sexual Dysfunction, SSRI Induced

Vankocin

Vankocin may be available in the countries listed below.

Ingredient matches for Vankocin

Vancomycin

Vancomycin is reported as an ingredient of Vankocin in the following countries:

• Serbia

International Drug Name Search

Haloperidol

In some countries, this medicine may only be approved for veterinary use.

In the US, Haloperidol (haloperidol systemic) is a member of the drug class miscellaneous antipsychotic agents and is used to treat Dementia, ICU Agitation, Mania, Nausea/Vomiting, Psychosis and Tourette's Syndrome.

US matches:

• Haloperidol


• Haloperidol Decanoate


• Haloperidol Solution


• Haloperidol Tablets


• Haloperidol Intramuscular


• Haloperidol Lactate


• Haloperidol Oral Solution

UK matches:

• Haloperidol 10mg Tablets (SPC)
• Haloperidol 20mg Tablets (SPC)
• Haloperidol Injection BP 5mg/ml (SPC)
• Haloperidol Tablets 0.5mg B.P. (SPC)
• Haloperidol Tablets 5mg B.P. (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AD01

CAS registry number (Chemical Abstracts Service)

0000052-86-8

Chemical Formula

C21-H23-Cl-F-N-O2

Molecular Weight

375

Therapeutic Category

Neuroleptic

Chemical Name

1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-

Foreign Names

• Haloperidolum (Latin)
• Haloperidol (German)
• Halopéridol (French)
• Haloperidol (Spanish)

Generic Names

• Aloperidolo (OS: DCIT)
• Haloperidol (OS: BAN, USAN, JAN)
• Halopéridol (OS: DCF)
• R 1625 (IS: Janssen)
• Haloperidol (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XIV)
• Halopéridol (PH: Ph. Eur. 6)
• Haloperidolum (PH: Ph. Int. 4, Ph. Eur. 6)
• Haloperidol Decanoate (OS: BANM, USAN)
• R 13672 (IS)
• Halopéridol (décanoate d') (PH: Ph. Eur. 6)
• Haloperidol Decanoate (PH: BP 2010, Ph. Eur. 6)
• Haloperidoldecanoat (PH: Ph. Eur. 6)
• Haloperidoli decanoas (PH: Ph. Eur. 6)

Brand Names

• Akroperidol
  ABL, Peru



• Aloperidolo Galenica
  Galenica, Italy



• Aloperidolo Salf
  Salf, Italy



• Apo-Haloperidol
  Apotex, Canada; Apotex, Singapore; Apotex, Taiwan; Apotex, Vietnam; Apotex Inc., Russian Federation



• Apracal
  Psipharma, Colombia



• Avant
  Medochemie, Malta; Medochemie, Taiwan



• Cosminal
  Towa Yakuhin, Japan



• Dozic
  Rosemont, United Kingdom



• Enabran
  Casasco, Argentina



• Esextin
  Kyorin Rimedio, Japan



• Govotil
  Guardian Pharmatama, Indonesia



• Haldol Decanoas
  Janssen-Cilag, Tunisia



• Haldol
  Eurim, Austria; Janssen, Antigua & Barbuda; Janssen, Netherlands Antilles; Janssen, Aruba; Janssen, Barbados; Janssen, Belgium; Janssen, Bermuda; Janssen, Brazil; Janssen, Bahamas; Janssen, Costa Rica; Janssen, Cyprus; Janssen, Germany; Janssen, Dominican Republic; Janssen, Ecuador; Janssen, Grenada; Janssen, Guatemala; Janssen, Guyana; Janssen, Hong Kong; Janssen, Honduras; Janssen, Israel; Janssen, Iceland; Janssen, Italy; Janssen, Jamaica; Janssen, Cayman Islands; Janssen, Lebanon; Janssen, Saint Lucia; Janssen, Sri Lanka; Janssen, Luxembourg; Janssen, Mexico; Janssen, Nicaragua; Janssen, Netherlands; Janssen, Norway; Janssen, Panama; Janssen, Peru; Janssen, Philippines; Janssen, Portugal; Janssen, Romania; Janssen, Saudi Arabia; Janssen, Sudan; Janssen, Suriname; Janssen, El Salvador; Janssen, Thailand; Janssen, Trinidad & Tobago; Janssen, Taiwan; Janssen, Saint Vincent & The Grenadines; Janssen, Venezuela; Janssen, Yemen; Janssen-Cilag, United Arab Emirates; Janssen-Cilag, Austria; Janssen-Cilag, Bahrain; Janssen-Cilag, Switzerland; Janssen-Cilag, Chile; Janssen-Cilag, Egypt; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Indonesia; Janssen-Cilag, Jordan; Janssen-Cilag, Malta; Janssen-Cilag, Oman; Janssen-Cilag, Sweden; Janssen-Cilag, Tunisia; Krka, Bosnia & Herzegowina; Krka, Croatia (Hrvatska); Krka, Serbia; Krka, Slovenia; Pharmaghreb, Tunisia



• Haldol (veterinary use)
  Janssen Animal Health, United Kingdom



• Haldomin
  Heng Hsin, Taiwan



• Halojust
  Tsuruhara Seiyaku, Japan



• Halomidol
  Choseido Pharmaceutical, Japan



• Halop
  Opsonin, Bangladesh



• Haloper
  CTS, Israel



• Haloper-CT
  CT Arzneimittel, Germany



• Haloperidol Akri
  Akrihin, Russian Federation



• Haloperidol Carrion
  Carrion, Peru



• Haloperidol Cevallos
  Cevallos, Argentina



• Haloperidol CF
  Centrafarm, Netherlands



• Haloperidol DBL
  DBL/Faulding, Bangladesh



• Haloperidol Denver
  Denver, Argentina



• Haloperidol Esteve
  Laboratorios Dr Esteve, Spain



• Haloperidol Gemepe
  Gemepe, Argentina



• Haloperidol Hexal
  Hexal, Germany



• Haloperidol Iqfarma
  Iqfarma, Peru



• Haloperidol Kern Pharma
  Kern, Spain



• Haloperidol Medipharma
  Medipharma, Argentina



• Haloperidol PCH
  Pharmachemie, Netherlands



• Haloperidol Prodes
  Almirall, Spain



• Haloperidol ratiopharm
  ratiopharm, Netherlands



• Halopéridol Renaudin
  Renaudin, France



• Haloperidol Richter
  Gedeon Richter, Bulgaria; Gedeon Richter, Czech Republic; Gedeon Richter, Estonia; Gedeon Richter, Georgia; Gedeon Richter, Lithuania; Gedeon Richter, Latvia; Richter Gedeon RT, Slovakia



• Haloperidol Sanderson
  Sanderson, Peru



• Haloperidol Sandoz
  Sandoz, Netherlands



• Haloperidol Stada
  Stada, Germany



• Haloperidol Vannier
  Vannier, Argentina



• Haloperidol
  Arena, Romania; Bestpharma, Chile; Biosano, Chile; Blaskov, Colombia; Canonpharma, Russian Federation; Gedeon Richter, Hungary; Gedeon Richter, Romania; Gedeon Richter, Russian Federation; Hemofarm, Serbia; Medifarm, Venezuela; Medopharm, Georgia; Mylan, United States; Par, United States; Polfa Warshavskiy, Russian Federation; Polfa Warszawa, Poland; Rider, Chile; Sanderson, Chile; Sandoz, Canada; Sandoz, United States; Terapia, Romania; Unia, Poland; Watson, United States; Zdravlje, Serbia; Zydus, United States



• Haloperidol-1A Pharma
  1A Pharma, Germany



• Haloperidol-Gry
  Teva, Germany



• Haloperidol-neuraxpharm
  Neuraxpharm, Germany



• Haloperidol-ratiopharm
  Ratiopharm, Germany; Ratiopharm, Luxembourg; Ratiopharm, Russian Federation



• Haloperidols Grindeks
  Grindeks, Latvia



• Haloperil
  Psicofarma, Mexico



• Halopidol
  Janssen, Argentina; Janssen, Colombia



• Halosten
  Shionogi, Taiwan; Shionogi Seiyaku, Japan



• Haloxen
  Remedica, Cyprus



• Halozen
  Bouzen, Argentina



• Haridol
  Atlantic, Myanmar



• Lemonamine
  Kyowa Yakuhin, Japan



• Limerix
  Ivax, Argentina



• Linton
  Tanabe Mitsubishi, Japan



• Lodomer
  Mersifarma, Indonesia



• Neupram
  Neuropharma, Argentina



• Neurodol
  Opalia, Tunisia



• Norodol
  ARIS, Turkey



• Peldol
  Gaco, Bangladesh



• Peridol
  Square, Bangladesh



• Peridor
  Unipharm, Israel



• Sandoz Haloperidol
  Sandoz, South Africa



• Sedaperidol
  Osel, Turkey



• Senorm
  Sun, Russian Federation



• Serenace
  Dainippon Sumitomo, Japan; Ivax, Ireland; Pfizer, Hong Kong; Pfizer, Indonesia; Pfizer, Philippines; Pfizer, South Africa; RPG, India; Searle Pharmaceuticals, Ethiopia; Sigma, Australia; Sigma, New Zealand; Teva Pharmaceuticals, United Kingdom



• Serenase
  Janssen, Finland; Janssen-Cilag, Denmark; Lusofarmaco, Italy



• Sevium
  Ni-The, Greece



• Sigaperidol
  Sigapharm, Germany



• Suirolin
  Tatsumi Kagaku, Japan



• Tiplac
  Roemmers, Venezuela



• Aloperidin
  Janssen, Greece



• Decaldol
  Polfa Warszawa, Poland



• Dozic (veterinary use)
  Rosemont, United Kingdom



• Haldol Concentrate
  Janssen, New Zealand



• Haldol decanoas Delphi
  Delphi, Netherlands



• Haldol decanoas Euro
  Euro, Netherlands



• Haldol decanoas Janssen
  Janssen, Netherlands



• Haldol decanoas Medcor
  Medcor, Netherlands



• Haldol Decanoas
  Janssen, Ecuador; Janssen, Hong Kong; Janssen, Israel; Janssen, Italy; Janssen, Sri Lanka; Janssen, Peru; Janssen, Thailand; Janssen, Taiwan; Janssen-Cilag, Switzerland; Janssen-Cilag, Chile; Janssen-Cilag, Indonesia; Janssen-Cilag, Malta; Janssen-Cilag, Oman



• Haldol Decanoat
  Eurim, Austria; Janssen-Cilag, Austria



• Haldol Decanoate
  Janssen, Australia; Janssen, Costa Rica; Janssen, Cyprus; Janssen, Guatemala; Janssen, Honduras; Janssen, Ireland; Janssen, Israel; Janssen, Lebanon; Janssen, Luxembourg; Janssen, Saudi Arabia; Janssen, Sudan; Janssen, El Salvador; Janssen, Yemen; Janssen-Cilag, United Arab Emirates; Janssen-Cilag, Egypt; Janssen-Cilag, Jordan



• Haldol Decanoato
  Janssen, Brazil



• Haldol depo
  Krka, Bosnia & Herzegowina; Krka, Slovenia



• Haldol depósito
  Janssen, Venezuela



• Haldol Depot
  Janssen, Iceland; Janssen, Norway



• Haldol
  Janssen, Belgium; Janssen, Ireland; Janssen, Myanmar; Janssen, Mexico; Janssen, New Zealand; Janssen, Philippines; Janssen-Cilag, Bahrain; Janssen-Cilag, United Kingdom; Krka, Croatia (Hrvatska); Ortho-McNeil, United States



• Haldol decanoas
  Janssen-Cilag, France



• Haldol Depot
  Janssen-Cilag, Sweden



• Haldol-Janssen Decanoat (veterinary use)
  Janssen, Germany



• Halo Decanoato
  Cristália, Brazil



• Halomonth
  Janssen Pharmaceutical K.K., Japan



• Haloperidol Decanoat
  Gedeon Richter, Hungary; Gedeon Richter, Romania



• Haloperidol Decanoate Richter
  Gedeon Richter, Czech Republic; Gedeon Richter, Estonia; Gedeon Richter, Lithuania; Gedeon Richter, Latvia; Richter Gedeon RT, Slovakia



• Haloperidol Decanoate
  Apotex, United States; APP, United States; Bedford, United States; Gedeon Richter, Russian Federation; Sandoz, United States; Sicor, United States



• Haloperidol Decanoato Denver
  Denver, Argentina



• Haloperidol Decanoato Gemepe
  Gemepe, Argentina



• Haloperidol-neuraxpharm Decanoat
  Neuraxpharm, Germany



• Halopidol Decanoato
  Janssen, Argentina; Janssen, Colombia



• Haridol-D
  Atlantic Laboratories, China



• Neoperidol
  Johnson & Johnson, Japan



• Pericate
  Unipharm, Israel



• Senorm
  Sun, Russian Federation



• Serenace (veterinary use)
  Ivax, United Kingdom



• Serenase Dekanoat
  Janssen-Cilag, Denmark



• Haldol
  Ortho-McNeil, United States



• Haloperidol Lactate
  Actavis, United States



• Haloperidol Larjan
  Veinfar, Argentina



• Haloperidol
  Akorn, United States; Apotex, United States; APP, United States; Bedford, United States; Gland, United States; Pharmaceutical Associates, United States; Sandoz, United States; Silarx, United States; Teva USA, United States; UDL, United States; Watson, United States

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Cefuroxime Sandoz

Cefuroxime Sandoz may be available in the countries listed below.

Ingredient matches for Cefuroxime Sandoz

Cefuroxime

Cefuroxime is reported as an ingredient of Cefuroxime Sandoz in the following countries:

• Romania

Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Cefuroxime Sandoz in the following countries:

• Belgium


• Bulgaria


• Estonia

International Drug Name Search

Mucinum

Mucinum may be available in the countries listed below.

Ingredient matches for Mucinum

Bisacodyl

Bisacodyl is reported as an ingredient of Mucinum in the following countries:

• Belgium

International Drug Name Search

Tamslon

Tamslon may be available in the countries listed below.

Ingredient matches for Tamslon

Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamslon in the following countries:

• Japan

International Drug Name Search

Dexamedix

Dexamedix may be available in the countries listed below.

Ingredient matches for Dexamedix

Dexamethasone

Dexamethasone is reported as an ingredient of Dexamedix in the following countries:

• Peru

International Drug Name Search

Anastralan

Anastralan may be available in the countries listed below.

Ingredient matches for Anastralan

Anastrozole

Anastrozole is reported as an ingredient of Anastralan in the following countries:

• Poland

International Drug Name Search

Salibet

Salibet may be available in the countries listed below.

Ingredient matches for Salibet

Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Salibet in the following countries:

• Oman

Salicylic Acid

Salicylic Acid is reported as an ingredient of Salibet in the following countries:

• Oman

International Drug Name Search

Hexabotin

Hexabotin may be available in the countries listed below.

Ingredient matches for Hexabotin

Erythromycin

Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Hexabotin in the following countries:

• Denmark

International Drug Name Search

Fitomenadiona

Fitomenadiona may be available in the countries listed below.

Ingredient matches for Fitomenadiona

Phytomenadione

Phytomenadione is reported as an ingredient of Fitomenadiona in the following countries:

• Chile


• Peru


• Romania

International Drug Name Search

Codipront mono

Codipront mono may be available in the countries listed below.

Ingredient matches for Codipront mono

Codeine

Codeine resinate (a derivative of Codeine) is reported as an ingredient of Codipront mono in the following countries:

• Luxembourg


• Venezuela

International Drug Name Search